Trial site
Neurology Rare Disease Center
Flower Mound, Texas 75028, United StatesNot linked to an institution yet
The trials here
What the 10 trials at this site are about, from their registry records.
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Biogen2 trials
- argenx1 trial
- CSL Behring1 trial
- Hoffmann-La Roche1 trial
- MED Institute Inc.1 trial
- and 4 more
Running trials
Recruiting
A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
NCT07444450· Phase 3· Biogen· Source
Contact: Diana Castro (principal investigator)
Recruiting
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
NCT07221669· Phase 3· Biogen· Source
Contact: Diana Castro (principal investigator)
Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
NCT07287982· Phase 2· argenx· Source
Contact: Natalie Gomez
Recruiting
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
NCT07160634· Phase 3· Solid Biosciences Inc.· Source
Contact: Jennifer Avelar, CRC
Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
NCT07047144· Phase 2· Scholar Rock, Inc.· Source
Contact: Jennifer Avelar
Active, not recruiting
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
NCT06450639· Phase 2· Hoffmann-La Roche· Source
Active, not recruiting
Study of UC-MSC in DMD Patients
NCT06579352· Phase 2· MED Institute Inc.· Source
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580· Phase 3· Vor Biopharma· Source
Recruiting
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
NCT04626674· Phase 1· Sarepta Therapeutics, Inc.· Source
Contact: Diana Castro, MD (principal investigator)
Recruiting
Two Dose Levels of Privigen in Pediatric CIDP
NCT03684018· Phase 4· CSL Behring· Source
Contact: Trial Registration Coordinator
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error